Trial of Combination ABI-007, Carboplatin, and Gemcitabine for First Line Treatment of Advanced Urothelial Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Bladder Cancer
Related studies linked through entity extraction aliases.
Radiation Therapy and Chemotherapy in Treating Patients With Stage I Bladder Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Duke Urology Database and Specimen Bank
- Status
- COMPLETED
- Phase
- N/A
Mitomycin C Versus Bacillus Calmette-Guerin in the Intravesical Treatment of Non-Muscle-Invasive Bladder Cancer Patients
- Status
- TERMINATED
- Phase
- PHASE3
Urine Cytology and Utility in Bladder Recurrence
- Status
- COMPLETED
- Phase
- N/A
Robotic-Assisted Laparoscopic Extended Pelvic Lymph Node Dissection for Transitional Cell Carcinoma of the Bladder
- Status
- COMPLETED
- Phase
- PHASE2
Biomarker Discovery and Application in Bladder Cancer
- Status
- UNKNOWN
- Phase
- N/A
A Study for Treatment of Superficial Bladder Cancer Using OGX-427
- Status
- UNKNOWN
- Phase
- PHASE1
Acceptability of Less Harmful Alternatives to Cigarettes
- Status
- COMPLETED
- Phase
- NA
A Double Blind Randomised Study of Lapatinib and Placebo in Metastatic TCC of the Urothelium
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
3 Tesla MRI in Patients With Bladder Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Trial to Evaluate Paclitaxel Plus RAD001 in Urothelial Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
A 12-Gene Blood-Based Signature for Detecting Metastatic Bladder Cancer
- Status
- TERMINATED
- Phase
- N/A
Cone Beam Computed Tomography (CT) Bladder
- Status
- COMPLETED
- Phase
- NA
A Genotype-Phenotype Urothelial Cancer Registry
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Biomarkers in Patients With Kidney Cancer or Cancer of the Urothelium and in Healthy Participants
- Status
- COMPLETED
- Phase
- N/A
Safety Study on AdCD40L Gene Therapy for Bladder Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of CP-675,206 in Bacillus Calmette-Guerin (BCG)-Resistant Bladder Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1
Randomized Study of Docetaxel +/- Vandetanib in Metastatic TCC
- Status
- COMPLETED
- Phase
- PHASE2
Molecular Analysis Of Bladder Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A